EDGEWISE THERAPEUTICS INC's ticker is EWTX and the CUSIP is 28036F105. A total of 79 filers reported holding EDGEWISE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,110,456 | -23.0% | 891,768 | +4.2% | 0.00% | 0.0% |
Q2 2023 | $6,635,643 | +28.3% | 856,212 | +10.4% | 0.00% | 0.0% |
Q1 2023 | $5,172,498 | +80031.6% | 775,487 | +7.4% | 0.00% | 0.0% |
Q4 2022 | $6,455 | -99.9% | 722,145 | +37.9% | 0.00% | 0.0% |
Q3 2022 | $5,151,000 | +63.1% | 523,521 | +31.9% | 0.00% | – |
Q2 2022 | $3,158,000 | -25.7% | 396,830 | -9.4% | 0.00% | -100.0% |
Q1 2022 | $4,249,000 | -29.0% | 438,141 | +11.9% | 0.00% | 0.0% |
Q4 2021 | $5,983,000 | +48.4% | 391,582 | +61.2% | 0.00% | 0.0% |
Q3 2021 | $4,032,000 | -22.0% | 242,919 | +0.2% | 0.00% | 0.0% |
Q2 2021 | $5,170,000 | – | 242,422 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 1,553,661 | $8,902,478 | 11.43% |
Novo Holdings A/S | 6,071,703 | $34,790,858 | 2.57% |
Orbimed Advisors | 14,567,176 | $83,469,918 | 1.77% |
Opaleye Management Inc. | 875,405 | $5,016,071 | 1.63% |
Cormorant Asset Management, LP | 2,946,887 | $16,885,663 | 0.98% |
DAFNA Capital Management LLC | 519,384 | $2,976,070 | 0.93% |
EcoR1 Capital, LLC | 3,493,194 | $20,016,002 | 0.68% |
Deep Track Capital, LP | 2,750,000 | $15,757,500 | 0.61% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,933,137 | $22,536,875 | 0.50% |
Parkman Healthcare Partners LLC | 473,312 | $2,712,078 | 0.50% |